Buprenorphine‐naloxone combination appears safe during pregnancy

A cohort study has found comparable neonatal and maternal outcomes for women receiving the combination of buprenorphine and naloxone in the first trimester of pregnancy and women receiving buprenorphine alone. The results suggest that both formulations of buprenorphine appear to be a safe choice for pregnant women with opioid use disorder (OUD).

Publication Details

Journal
The Brown University Psychopharmacology Update
Published
2024-11-05
DOI
https://doi.org/10.1002/pu.31238
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Buprenorphine‐naloxone combination appears safe during pregnancy

The Brown University Psychopharmacology Update
Prenatal Substance Exposure Effects
article

Buprenorphine‐naloxone combination appears safe during pregnancy

article en

Abstract

A cohort study has found comparable neonatal and maternal outcomes for women receiving the combination of buprenorphine and naloxone in the first trimester of pregnancy and women receiving buprenorphine alone. The results suggest that both formulations of buprenorphine appear to be a safe choice for pregnant women with opioid use disorder (OUD).

The Brown University Psychopharmacology UpdateVol. 35(12)
Good health and well-being
Openalex Percentile: Top 69%
Prenatal Substance Exposure Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Buprenorphine‐naloxone combination appears safe during pregnancy · The Brown University Psychopharmacology Update (2024) | TGRS Research Map | TGRS